Figure 3: Immunocytochemical staining after treatment with an optical clearing agent.
a. Ki-67 Clearing agent, 10 min(pleural effusion)
b. Ki-67 Control 2(pleural effusion)
c. MOC31 Clearing agent, 10 min (ascites)
d. MOC31 Control 2 (ascites).